Westchester Capital Management (New York)’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-495,273
Closed -$4.93M 530
2022
Q2
$4.93M Buy
495,273
+2,203
+0.4% +$21.8K 0.14% 137
2022
Q1
$4.88M Buy
493,070
+294,349
+148% +$2.9M 0.13% 145
2021
Q4
$1.96M Buy
198,721
+15,010
+8% +$148K 0.06% 212
2021
Q3
$1.81M Buy
183,711
+8,222
+5% +$80.2K 0.05% 184
2021
Q2
$1.72M Buy
175,489
+164,003
+1,428% +$1.6M 0.04% 173
2021
Q1
$112K Buy
+11,486
New +$111K ﹤0.01% 318

Westchester Capital Management (New York)'s ISLE Position: Q3 2022 in Review

Westchester Capital Management (New York) sold out of Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q3 2022, closing a stake of 495,273 shares — an estimated $4.93M sold.

Westchester Capital Management (New York) first reported a position in ISLE in Q1 2021 and held it in 6 quarters. The position peaked at $4.93M in Q2 2022. 0 funds tracked by Wall St. Rank hold ISLE as of Q3 2022.

  • Westchester Capital Management (New York) reported no remaining Isleworth Healthcare Acquisition Corporation Common stock position as of Q3 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 495,273 Isleworth Healthcare Acquisition Corporation Common stock shares in Q3 2022, an estimated $4.93M.
  • Westchester Capital Management (New York) first reported a position in Isleworth Healthcare Acquisition Corporation Common stock in Q1 2021 and held it in 6 quarters.
  • Westchester Capital Management (New York)'s Isleworth Healthcare Acquisition Corporation Common stock position peaked at $4.93M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q3 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q3 2022, filed 15 Nov 2022.